Abstract
Since the identification of the novel reassortant avian influenza A (H7N9) virus in China in 2013, until Jun 30, 2017, the virus has caused five epidemic waves leading to a total of 1,552 human infections, with a fatality rate of about 40%. In the spring of 2017, highly pathogenic avian influenza (HPAI) H7N9 virus emerged and has caused 25 human infections. The HPAI H7N9 virus has some biological differences from the LPAI one, such as its multiple basic amino acid residues on HA leading to its independence on trypsin for replication. The pathogenicity of the HPAI H7N9 virus to experimental animals or humans is still unclear. A(H7N9) vaccine development for pandemic preparedness is ongoing, including the reassortment (H7N9/PR8) reverse genetic based vaccine, the virus like particle (VLP) vaccine, the intranasal live attenuated influenza vaccine (LAIV), the non-adjuvant Vero cell culture-derived inactivated whole-virus vaccine, the MDCK culture-derived vaccine, the H7 DNA vaccine and the recombinant replicative H7N9 virus (H7N9-53TM) vaccine. Five neuramidinase resistant sites of A(H7N9) virus isolated from patients have been reported. Some alternative drugs have been studied, such as DAS181 (Fludase), ribavirin, troglitazone and minocycline. Persistent surveillance and enhanced global control are essential to fight against human infections with A(H7N9) virus.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bi, Y., Wong, G., Liu, Y., Liu, L., Gao, G.F., and Shi, Y. (2016). Ribavirin is effective against drug-resistant H7N9 influenza virus infections. Protein Cell 7, 611–614.
Chen, H., Liu, S., Liu, J., Chai, C., Mao, H., Yu, Z., Tang, Y., Zhu, G., Chen, H.X., Zhu, C., Shao, H., Tan, S., Wang, Q., Bi, Y., Zou, Z., Liu, G., Jin, T., Jiang, C., Gao, G.F., Peiris, M., Yu, H., and Chen, E. (2016). Nosocomial co-transmission of avian influenza A(H7N9) and A(H1N1)pdm09 viruses between 2 patients with hematologic disorders. Emerg Infect Dis 22, 598–607.
Chia, M.Y., Hu, A.Y.C., Tseng, Y.F., Weng, T.C., Lai, C.C., Lin, J.Y., Chen, P.L., Wang, Y.F., Chao, S.R., Chang, J.Y., Hwang, Y.S., Yeh, C.T., Yu, C.P., Chen, Y.C., Su, I.J., and Lee, M.S. (2015). Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets. PLoS ONE 10, e0120793.
Fries, L.F., Smith, G.E., and Glenn, G.M. (2013). A recombinant viruslike particle influenza A (H7N9) vaccine. N Engl J Med 369, 2564–2566.
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., Xu, X., Lu, H., Zhu, W., Gao, Z., Xiang, N., Shen, Y., He, Z., Gu, Y., Zhang, Z., Yang, Y., Zhao, X., Zhou, L., Li, X., Zou, S., Zhang, Y., Li, X., Yang, L., Guo, J., Dong, J., Li, Q., Dong, L., Zhu, Y., Bai, T., Wang, S., Hao, P., Yang, W., Zhang, Y., Han, J., Yu, H., Li, D., Gao, G.F., Wu, G., Wang, Y., Yuan, Z., and Shu, Y. (2013). Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368, 1888–1897.
Gillman, A., Nykvist, M., Muradrasoli, S., Söderström, H., Wille, M., Daggfeldt, A., Bröjer, C., Waldenström, J., Olsen, B., and Järhult, J.D. (2015). Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water. Antimicrob Agents Chemother 59, 5196–5202.
Gubareva, L.V., Sleeman, K., Guo, Z., Yang, H., Hodges, E., Davis, C.T., Baranovich, T., and Stevens, J. (2017). Drug susceptibility evaluation of an influenza A(H7N9) virus by analyzing recombinant neuraminidase proteins. J Infect Dis 216, S566–S574.
Hoffmann, J., Otte, A., Thiele, S., Lotter, H., Shu, Y., and Gabriel, G. (2015). Sex differences in H7N9 influenza A virus pathogenesis. Vaccine 33, 6949–6954.
Imai, M., Watanabe, T., Kiso, M., Nakajima, N., Yamayoshi, S., Iwatsuki- Horimoto, K., Hatta, M., Yamada, S., Ito, M., Sakai-Tagawa, Y., Shirakura, M., Takashita, E., Fujisaki, S., McBride, R., Thompson, A.J., Takahashi, K., Maemura, T., Mitake, H., Chiba, S., Zhong, G., Fan, S., Oishi, K., Yasuhara, A., Takada, K., Nakao, T., Fukuyama, S., Yamashita, M., Lopes, T.J.S., Neumann, G., Odagiri, T., Watanabe, S., Shu, Y., Paulson, J.C., Hasegawa, H., and Kawaoka, Y. (2017). A highly pathogenic avian H7N9 influenza virus isolated from a human is lethal in some ferrets infected via respiratory droplets. Cell Host Microbe 22, 615–626.
Jin, Y., Yu, D., Ren, H., Yin, Z., Huang, Z., Hu, M., Li, B., Zhou, W., Yue, J., and Liang, L. (2014). Phylogeography of avian influenza A H9N2 in China. BMC Genomics 15, 1110.
Josset, L., Zeng, H., Kelly, S.M., Tumpey, T.M., and Katze, M.G. (2014). Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options. mBio 5, e01102–13–e01102–13.
Kong, H., Zhang, Q., Gu, C., Shi, J., Deng, G., Ma, S., Liu, J., Chen, P., Guan, Y., Jiang, Y., and Chen, H. (2015). A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals. Sci Rep 5, 11233.
Li, Q., Zhou, L., Zhou, M., Chen, Z., Li, F., Wu, H., Xiang, N., Chen, E., Tang, F., Wang, D., Meng, L., Hong, Z., Tu, W., Cao, Y., Li, L., Ding, F., Liu, B., Wang, M., Xie, R., Gao, R., Li, X., Bai, T., Zou, S., He, J., Hu, J., Xu, Y., Chai, C., Wang, S., Gao, Y., Jin, L., Zhang, Y., Luo, H., Yu, H., He, J., Li, Q., Wang, X., Gao, L., Pang, X., Liu, G., Yan, Y., Yuan, H., Shu, Y., Yang, W., Wang, Y., Wu, F., Uyeki, T.M., and Feng, Z. (2014). Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med 370, 520–532.
Liu, J., Xiao, H., Wu, Y., Liu, D., Qi, X., Shi, Y., and Gao, G.F. (2014). H7N9: a low pathogenic avian influenza A virus infecting humans. Curr Opin Virol 5, 91–97.
Liu, M., Song, T.R., Hua, S., Wu, A.P., and Jiang, T.J. (2015). Computational analysis of antigenic epitopes of avian influenza A (H7N9) viruses. Sci China Life Sci 58, 687–693.
Marjuki, H., Mishin, V.P., Chesnokov, A.P., De La Cruz, J.A., Fry, A.M., Villanueva, J., and Gubareva, L.V. (2014). An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality. J Infect Dis 210, 435–440.
Mok, C.K.P., Lee, H.H.Y., Chan, M.C.W., Sia, S.F., Lestra, M., Nicholls, J.M., Zhu, H., Guan, Y., and Peiris, J.M.S. (2013). Pathogenicity of the novel A/H7N9 influenza virus in mice. mBio 4, e00362–13–e00362–13.
Qi, X., Qian, Y.H., Bao, C.J., Guo, X.L., Cui, L.B., Tang, F.Y., Ji, H., Huang, Y., Cai, P.Q., Lu, B., Xu, K., Shi, C., Zhu, F.C., Zhou, M.H., and Wang, H. (2013). Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ 347, f4752–f4752.
Richard, M., Schrauwen, E.J.A., de Graaf, M., Bestebroer, T.M., Spronken, M.I.J., van Boheemen, S., de Meulder, D., Lexmond, P., Linster, M., Herfst, S., Smith, D.J., van den Brand, J.M., Burke, D.F., Kuiken, T., Rimmelzwaan, G.F., Osterhaus, A.D.M.E., and Fouchier, R.A.M. (2013). Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501, 560–563.
Shi, J.Z., Deng, G.H., Liu, P.H., Zhou, J.P., Guan, L.Z., Li, W.H., Li, X.Y., Guo, J., Wang, G.J., Fan, J., Wang, J.L., Li, Y.Y., Jiang, Y.P., Liu, L.L., Tian, G.B., Li, C.J., and Chen, H.L. (2013). Isolation and characterization of H7N9 viruses from live poultry markets—implication of the source of current H7N9 infection in humans. Chin Sci Bull 58, 1857–1863.
Smith, G.E., Flyer, D.C., Raghunandan, R., Liu, Y., Wei, Z., Wu, Y., Kpamegan, E., Courbron, D., Fries Iii, L.F., and Glenn, G.M. (2013). Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. Vaccine 31, 4305–4313.
Song, M.S., Marathe, B.M., Kumar, G., Wong, S.S., Rubrum, A., Zanin, M., Choi, Y.K., Webster, R.G., Govorkova, E.A., and Webby, R.J. (2015). Unique determinants of neuraminidase inhibitor resistance among N3, N7, and N9 avian influenza viruses. J Virol 89, 10891–10900.
Wang, D., Yang, L., Gao, R., Zhang, X., Tan, Y., Wu, A., Zhu, W., Zhou, J., Zou, S., Li, X., Sun, Y., Zhang, Y., Liu, Y., Liu, T., Xiong, Y., Xu, J., Chen, L., Weng, Y., Qi, X., Guo, J., Li, X., Dong, J., Huang, W., Zhang, Y., Dong, L., Zhao, X., Liu, L., Lu, J., Lan, Y., Wei, H., Xin, L., Chen, Y., Xu, C., Chen, T., Zhu, Y., Jiang, T., Feng, Z., Yang, W., Wang, Y., Zhu, H., Guan, Y., Gao, G., Li, D., Han, J., Wang, S., Wu, G., and Shu, Y. (2014). Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Euro Surveill 19, pii: 20836.
Wang, D., Yang, L., Zhu, W., Zhang, Y., Zou, S., Bo, H., Gao, R., Dong, J., Huang, W., Guo, J., Li, Z., Zhao, X., Li, X., Xin, L., Zhou, J., Chen, T., Dong, L., Wei, H., Li, X., Liu, L., Tang, J., Lan, Y., Yang, J., and Shu, Y. (2016). Two outbreak sources of influenza A (H7N9) viruses have been established in China. J Virol 90, 5561–5573.
Wang, X., Jiang, H., Wu, P., Uyeki, T.M., Feng, L., Lai, S., Wang, L., Huo, X., Xu, K., Chen, E., Wang, X., He, J., Kang, M., Zhang, R., Zhang, J., Wu, J., Hu, S., Zhang, H., Liu, X., Fu, W., Ou, J., Wu, S., Qin, Y., Zhang, Z., Shi, Y., Zhang, J., Artois, J., Fang, V.J., Zhu, H., Guan, Y., Gilbert, M., Horby, P.W., Leung, G.M., Gao, G.F., Cowling, B.J., and Yu, H. (2017a). Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis 17, 822–832.
Wang, Y., Wu, J., Xue, C., Wu, Z., Lin, Y., Wei, Y., Wei, X., Qin, J., Zhang, Y., Wen, Z., Chen, L., Liu, G.D., and Cao, Y. (2017b). A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice. Antiviral Res 143, 97–105.
Wodal, W., Schwendinger, M.G., Savidis-Dacho, H., Crowe, B.A., Hohenadl, C., Fritz, R., Brühl, P., Portsmouth, D., Karner-Pichl, A., Balta, D., Grillberger, L., Kistner, O., Barrett, P.N., and Howard, M.K. (2015). Immunogenicity and protective efficacy of a vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs. PLoS ONE 10, e0113963.
Yang, J.R., and Liu, M.T. (2017). Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, 2017. J Formosan Med Assoc 116, 210–212.
Yang, L., Zhu, W., Li, X., Chen, M., Wu, J., Yu, P., Qi, S., Huang, Y., Shi, W., Dong, J., Zhao, X., Huang, W., Li, Z., Zeng, X., Bo, H., Chen, T., Chen, W., Liu, J., Zhang, Y., Liang, Z., Shi, W., Shu, Y., and Wang, D. (2017). Genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in mainland China. J Virol in press doi: 10.1128/JVI.01277-17.
Zhang, F., Bi, Y., Wang, J., Wong, G., Shi, W., Hu, F., Yang, Y., Yang, L., Deng, X., Jiang, S., He, X., Liu, Y., Yin, C., Zhong, N., and Gao, G.F. (2017). Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China. J Infect 75, 71–75.
Zhou, J., Wang, D., Gao, R., Zhao, B., Song, J., Qi, X., Zhang, Y., Shi, Y., Yang, L., Zhu, W., Bai, T., Qin, K., Lan, Y., Zou, S., Guo, J., Dong, J., Dong, L., Zhang, Y., Wei, H., Li, X., Lu, J., Liu, L., Zhao, X., Li, X., Huang, W., Wen, L., Bo, H., Xin, L., Chen, Y., Xu, C., Pei, Y., Yang, Y., Zhang, X., Wang, S., Feng, Z., Han, J., Yang, W., Gao, G.F., Wu, G., Li, D., Wang, Y., and Shu, Y. (2013). Biological features of novel avian influenza A (H7N9) virus. Nature 499, 500–503.
Zhou, L., Tan, Y., Kang, M., Liu, F., Ren, R., Wang, Y., Chen, T., Yang, Y., Li, C., Wu, J., Zhang, H., Li, D., Greene, C.M., Zhou, S., Iuliano, A.D., Havers, F., Ni, D., Wang, D., Feng, Z., Uyeki, T.M., and Li, Q. (2017). Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017. Emerg Infect Dis 23, 1355–1359.
Zhu, H., Wang, D., Kelvin, D.J., Li, L., Zheng, Z., Yoon, S.W., Wong, S.S., Farooqui, A., Wang, J., Banner, D., Chen, R., Zheng, R., Zhou, J., Zhang, Y., Hong, W., Dong, W., Cai, Q., Roehrl, M.H.A., Huang, S.S.H., Kelvin, A.A., Yao, T., Zhou, B., Chen, X., Leung, G.M., Poon, L.L.M., Webster, R.G., Webby, R.J., Peiris, J.S.M., Guan, Y., and Shu, Y. (2013). Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341, 183–186.
Zhu, W., Zhou, J., Li, Z., Yang, L., Li, X., Huang, W., Zou, S., Chen, W., Wei, H., Tang, J., Liu, L., Dong, J., Wang, D., and Shu, Y. (2017). Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017. Euro Surveill 22, 30533.
Zhuang, Q.Y., Wang, S.C., Wu, M.L., Liu, S., Jiang, W.M., Hou, G.Y., Li, J.P., Wang, K.C., Yu, J.M., Chen, J.M., and Chen, J.W. (2013). Epidemiological and risk analysis of the H7N9 subtype influenza outbreak in China at its early stage. Chin Sci Bull 58, 3183–3187.
Acknowledgements
This work was supported by the National Key Research and Development Program of China (2016YFD0500208 to Dayan Wang). The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of China CDC or other organizations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, J., Wang, D. Research progress in human infection with avian influenza H7N9 virus. Sci. China Life Sci. 60, 1299–1306 (2017). https://doi.org/10.1007/s11427-017-9221-4
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-017-9221-4